바로가기메뉴

본문 바로가기 주메뉴 바로가기

The Relationship between Expression of EGFR, MMP-9, and C-erbB-2 and Survival Time in Resected Non-Small Cell Lung Cancer

Tuberculosis & Respiratory Diseases / Tuberculosis & Respiratory Diseases,
2005, v.59 no.3, pp.286-297




















  • Downloaded
  • Viewed

Abstract

keywords
Non-Small Cell Lung Cancer, EGFR, MMP-9, C-erbB-2, Non-Small Cell Lung Cancer, EGFR, MMP-9, C-erbB-2

Reference

1.

(2001) Epidemiology of lung cancer Textbook of respiratory medicine, company

2.

(2004) HER1/EGFR targeting:refining the strategy,

3.

(2001) A biological staging model for operable non-small cell lung cancer,

4.

(1999) Regulation of matrix metalloproteinase expression in tumor invasion,

5.

(2003) Morphometric evaluation of tumor matrix metalloproteinase 9 predicts survival after surgical resection of adeno-carcinoma of the lung, Clin Cancer Res

6.

(1993) Correlation of intrinsic chemoresistance of non-small cell lung cancer cell lines with HER-2/neu gene expression but not with ras gene mutations,

7.

(2002) P185HER-2/neu and P21CIP1/WAF1 expression in primary tumors and lymph node metastases in Non-small lung cance,

8.

(1996) Lack of prognostic significance of epidermal growth factor receptor and the oncoprotein p185 HER-2 patients with systematically untreated non-small cell lung cancer an immunohistochemical study on cryosections,

9.

(1990) P185neu expression in human lung adenocarcinomas predicts shortened survival,

10.

(1997) Prediction of recurrence by quantification of p 185neu protein in non-small cell lung cancer tissue,

11.

(2001) Inhibition of growth factor production and angiogenesis in human cander cells by ZD1839(Irresa)a selective epidermal growth factor receptor tyrosine kinase inhibitor, Clin Cancer Res

12.

(2000) Matrix metalloproteinases:molecular aspects of their roles in tumour invasion and metastasis,

13.

(2000) improves estimation of prognosis in potentially curative resected non-small cell lung cancer,

14.

(1993) Association between expression of 72-kilodalton gelatinase and tumour spread in non-small cell lung cancer,

15.

(1998) Role of the plasminogen activator and matrix metalloproteinase systems in epidermal growth factor and scatter factor stimulated invasion of carcinoma cells,

16.

(2000) Overexpression of epidermal growth factor receptor in human head and neck squamous carcinoma cell lines correlates with matrix metalloproteinase-9 expression and in vitro invsion,

17.

(2000) MMP-9 and the epidermal growth factor receptor signal pathway in operable non-small cell lung cancer, Clin Cancer Res

18.

(1998) Down regulation of E-cadherin in mouse skin carcinoma cells enhance a migratory and invasive phenotype linked to matrix metalloproteinase-9 gelatinase expression,

19.

(1997) Expression of EGFR in non-small cell lung cancer and effects on survival,

20.

(2004) Epidermal growth factor receptor overexpression correlates with a poor prognosis in completely resected non-small-cell lung cancer,

21.

(2003) Prognostic impact of matrix metalloproteinase-9 in operable non-small cell lung cancer,

22.

(2001) Towards a biological staging model for operable non-small cell lung cancer,

23.

(1997) Immunocytochemical markers in stage I lung cancer:relevance to prognosis,

Tuberculosis & Respiratory Diseases